Congratulations to one of BaseLaunch’s portfolio companies, Polyneuron on their latest milestone: First clinical trial application approval. Wishing you great success with the studies later this year for validation of the Antibody-Catch.™ Download the press release here. Share this article Tweet Share View all news Sign up to receive our newsletter in your inbox. Sign up